Abstract
Clinical, radiological, and laboratory data of 62 patients with respiratory tuberculosis were studied with the purpose of comparative analysis of clinical efficacy of Glutoxime and Tubosan and evaluation of efficiency of the empirical approach in drug selection. Three groups of patients were formed: the 1st group - 20 patients who received Glutoxim along with anti-tuberculosis drugs. Group 2 - 23 patients (Tubosan), Group 3 – control, 19 patients (only anti-tuberculosis drugs). Empirical approach to the choice of pathogenetic drugs has a limited positive effect on the efficacy and tolerability of etiotropic therapy. In the conditions of forced polypragmasy, the prescription of drugs should be justified by modern highly informative criteria, not being limited only by clinical indications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
